Cystectomy
23
8
8
8
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
8.7%
2 terminated out of 23 trials
80.0%
-6.5% vs benchmark
13%
3 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (23)
Lidocaine for LESS Postoperative Shoulder Pain Alleviation
Exploring the Impact of Genetic Variations on The Clinical Efficacy of Nalbuphine in Postoperative Pain Management
Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
Use of Wearables Following Cystectomy- Part II
Robot-assisted Cystectomies With Regard to Blood Loss, Pain and Transfusions.
Supporting Sexual Recovery in Women With Bladder Cancer
Radical Cystectomy Versus Tri-Modal Therapy for Treatment of cT2N0M0 Urinary Bladder Transitional Cell Carcinoma
A Home-based Lifestyle Intervention for Optimizing Surgical Outcomes Among Urinary Bladder Cancer Patients
Thoracic Epidural Analgesia Versus Rectus Sheath Block Versus Surgeon Infiltration With Liposomal Bupivacaine or Standard Bupivacaine for Post-Operative Pain Control After Cystectomy
Introduction of Mycotic Prophylaxis At Cystectomy Trial.
Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis
Pediatric Ovarian Tissue Banking - Operative Specimens From Females 0-18 Years of Age
Erector Spinae Plane Block for Major Gynecologic and Urologic Surgery
Patient-Centered Surgical Prehabilitation
Benefit of Hemostatic Sealant in Preservation of Ovarian Reserve
Study of the Quality of Life of Patients Treated by Heavy Surgery as Part of an Enhanced Recovery at Beau Soleil Clinic- QUALICHIR
Time Efficiency of Intracorporeal Orthotopic Diversion With Robotic Staplers After Robot Assisted Radical Cystectomy
Evaluation of Robot-assisted Intracorporeal Urinary Reconstruction
Radical Cystectomy, Nutrition and Convalescence
A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before Cystectomy